Literature DB >> 6389243

Effect of contact material on vibration-induced insulin aggregation.

V Feingold, A B Jenkins, E W Kraegen.   

Abstract

The tendency of insulin to form insoluble aggregates is a major obstacle to the development of implantable insulin infusion systems for treatment of insulin-deficient diabetic patients. A test system was developed to examine the kinetics of insulin aggregation under controlled conditions of temperature, vibration and contact material in an effort to provide design criteria for minimising aggregation. The contact materials tested were all potentially suitable for pump reservoirs on engineering criteria and included metals (stainless steel, titanium and a titanium alloy) and various plastics (polypropylene, polytetrafluoroethylene, polyvinylchloride, polyamide, cellulose butyrate and silicone elastomer). The rate of insulin aggregation was markedly affected by the nature of the contact material. Hydrophilic materials, particularly polyamide and cellulose butyrate (2% of total insulin aggregated after 96 h vibration), appeared more compatible with insulin stability than did hydrophobic ones, such as polypropylene (16% aggregation) and polyvinylchloride (37% aggregation). A specially formulated 'pump' insulin preparation, stabilised by addition of polyethylenepolypropyleneglycol, was significantly superior (three to five times more stable) to a regular neutral insulin formulation under most, but not all, conditions. Standard clinical syringes (polypropylene) performed poorly with both insulin formulations but especially with the neutral regular insulin (100% aggregation after 96 h vibration). In addition to physical aggregates, significant amounts (5%-30%) of the insulin remaining in solution were no longer detectable by immuno- or receptorassay in all materials tested.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389243     DOI: 10.1007/bf00304853

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  Assay of insulin in vitro by fibril elongation and precipitation.

Authors:  D F WAUGH; R E THOMPSON; R J WEIMER
Journal:  J Biol Chem       Date:  1950-07       Impact factor: 5.157

Review 2.  Insulin aggregation in artificial delivery systems.

Authors:  W D Lougheed; H Woulfe-Flanagan; J R Clement; A M Albisser
Journal:  Diabetologia       Date:  1980-07       Impact factor: 10.122

3.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

4.  The use of an implantable insulin pump in the treatment of type II diabetes.

Authors:  W M Rupp; J J Barbosa; P J Blackshear; H B McCarthy; T D Rohde; F J Goldenberg; T G Rublein; F D Dorman; H Buchwald
Journal:  N Engl J Med       Date:  1982-07-29       Impact factor: 91.245

5.  Association of insulin pump therapy with raised serum amyloid A in type I diabetes mellitus.

Authors:  M Brownlee; H Vlassara; A Cerami; T R Martin; J J Li; K P McAdam
Journal:  Lancet       Date:  1984-02-25       Impact factor: 79.321

6.  Insulin delivery and the artificial beta cell: luminal obstructions in capillary conduits.

Authors:  W Lougheed; A M Albisser
Journal:  Int J Artif Organs       Date:  1980-01       Impact factor: 1.595

7.  Unanticipated amyloidosis in dogs infused with insulin.

Authors:  A M Albisser; K P McAdam; K Perlman; S Carson; A Bahoric; J R Williamson
Journal:  Diabetes       Date:  1983-12       Impact factor: 9.461

8.  Failure to find amyloidosis in dogs treated with long-term intravenous insulin delivered by a totally implantable pump.

Authors:  S M Mauer; H Buchwald; T J Groppoli; T D Rohde; B D Wigness; W M Rupp; M W Steffes
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

9.  Physical stability of insulin formulations.

Authors:  W D Lougheed; A M Albisser; H M Martindale; J C Chow; J R Clement
Journal:  Diabetes       Date:  1983-05       Impact factor: 9.461

10.  Insulin precipitation in artificial infusion devices.

Authors:  D E James; A B Jenkins; E W Kraegen; D J Chisholm
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

View more
  5 in total

1.  Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces.

Authors:  V Sluzky; J A Tamada; A M Klibanov; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 2.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

3.  pH-dependent self-association of zinc-free insulin characterized by concentration-gradient static light scattering.

Authors:  Arun K Attri; Cristina Fernández; Allen P Minton
Journal:  Biophys Chem       Date:  2010-02-08       Impact factor: 2.352

4.  Compatibility of insulin Lispro, Aspart, and Glulisine with the Solo MicroPump, a novel miniature insulin pump.

Authors:  Gil Senesh; Doron Bushi; Avraham Neta; Ofer Yodfat
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

Review 5.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.